Skip to main content

Table 2 Mean daily GH dose in Noonan syndrome (NS) and Turner syndrome (TS) patients over 4 years of GH treatment

From: Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program

 

NS

TS

GH dose μg/kg/day

GH dose μg/kg/day

Mean ± SD (n)

Mean ± SD (n)

Baseline

44.32 ± 9.63 (27)

48.24 ± 13.20 (282)

Year 1

49.33 ± 11.82 (30)

48.20 ± 12.03 (286)

Year 2

50.86 ± 12.19 (27)

47.90 ± 12.41 (287)

Year 3

50.46 ± 13.04 (28)

47.47 ± 13.57 (288)

Year 4

49.78 ± 13.56 (27)

46.50 ± 12.90 (267)